(Eh) y metanólico (Em) de Pera distichophylla sobre un aislado de ...

M. T. GALáN-PUCHADES and A. OSUNA
17. KLOETZEL K, CHIEFFI PP, FALEIROS JJ, FILHO
TJ. 1977. Mortality and other parameters of concomitant
infections in albino mice: the Schistosoma-Toxoplasma
model. Trop Geogr Med 29: 407-410.
18. KLOETZEL K, FALEIROS JJ, RUAS MENDES S,
STANLEY CT, SANCHES ARIAS H. 1973. Concomitant
infection of albino mice by Trypanosoma cruzi and
Schistosoma mansoni parasitological parameters. Trans
Roy Soc Trop Med Hyg 67: 652-658.
19. KOLBAUM J, RITTER, U, ZIIMARA N, BREWIG N,
ESCHBACH BRELOER, M. 2011. Efficient control of
Leishmania and Strongyloides despite partial suppression
of nematode-induced Th2 response in co-infected
mice. Parasite Immunol 33: 226-235.
20. LA FLAMME AC, SCOTT P, PEARCE EJ. 2002.
Schistosomiasis delays lesion resolution during Leishmania
major infection by impairing parasite killing by
macrophages. Parasite Immunol 24: 339-345.
21. LAMB TJ, GRAHAM AL, LE GOFF L, ALLEN JE.
2005. Co-infected C57BL/6 mice mount appropriately
polarized and compartmentalized cytokine responses to
Litomosoides sigmodontis and Leishmania major but
disease progression is altered. Parasite Immunol 27:
317-324.
22. LIESENFELD O, DUNAY IR, ERB KJ. 2004. Infection
with Toxoplasma gondii Reduces Established and
Developing Th2 Responses Induced by Nippostrongylus
brasiliensis Infection. Infect Immun 72: 3812-3822.
23. MARSHALL AJ, BRUNET LR, VAN GESSEL Y, AL-
CARAZ A, BLISS SK, PEARCE EJ, DENKERS EY.
1999. Toxoplasma gondii and Schistosoma mansoni
Synergize to Promote Hepatocyte Dysfunction Associated
with High Levels of Plasma TNF-a and Early
Death in C57BL/6 Mice. J Immunol 163: 2089-2097.
24. METENOU S, DEMBELE B, KONATE S, DOLO
H, COULIBALY YI, DIALLO AA, SOUMAORO
L, COULIBALY ME, COULIBALY SY, SANOGO
D, DOUMBIA SS, TRAORÉ SF, MAHANTY S,
KLION A, NUTMAN TB. 2011. Filarial Infection
Suppresses Malaria-Specific Multifunctional Th1 and
Th17 Responses in Malaria and Filarial Coinfections. J
Immunol 186: 4725-4733.
25. MILLER CMD, SMITH NC, IKIN RJ, BOULTER
NR, DALTON JP, DONELLY S. 2009. Immunological
Interactions between 2 Common Pathogens, Th1-
Inducing Protozoan Toxoplasma gondii and the Th2-
Inducing Helminth Fasciola hepatica. PLoS ONE 4:
e5692. doi:10.1371/journal.pone.0005692.
26. MIYAZAKI Y, HAMANO S, WANG S, SHIMANOE
Y, IWAKURA Y, YOSHIDA H. 2010. IL-17 is necessary
for host protection against acute-phase Trypanosoma
cruzi infection. J Immunol 185: 1150-1157.
27. MONTEIRO RV, DIETZ JM, JANSEN AM. 2010.
The impact of concomitant infections by Trypanosoma
cruzi and intestinal helminths on the health of wild
golden and golden-headed lion tamarins. Res Vet. Sci
89: 27-35.
28. MONTEIRO RV, DIETZ JM, RABOY B, BECK B,
VLEESCHOWER KD, BAKER A, MARTINS A,
JANSEN AM. 2007. Parasite community interactions:
Trypanosoma cruzi and intestinal helminths infecting
wild golden lion tamarins Leontopithecus rosalia and
golden-headed lion tamarins L. chrysomelas (Callitri-
12
chidae, L., 1766). Parasitol Re 101: 1689-1698.
29. MOREAU E, CHAUVIN A. 2010. Immunity against
Helminths: Interactions with the Host and the Intercurrent
Infections. J Biomed Biotechnol. ID428593: 1-9
doi: 10.1155/2010/428593.
30. MURRAY J, MURRAY A, MURRAY M, MURRAY
C. 1978. The biological suppression of malaria: an
ecological and nutritional interrelationship of a host
and two parasites. Am. J Clin Nutr 31: 1363-1366.
31. NACHER M. 2001. Malaria vaccine trials in a wormy
world. Trends Parasitol 17: 563-565.
32. NOLAND GS, CHOWDHURY DR, URBAN JF Jr,
ZAVALA F, KUMAR N. 2010. Helminth infection impairs
the immunogenicity of a Plasmodium falciparum
DNA vaccine, but not irradiated sporozoites, in mice.
Vaccine 28: 2917-2923.
33. OJURONGBE O, ADEGBAYI AM, BOLAJI OS,
AKINDELE AA, ADEFIOYE OA, ADEYEBA OA.
2011. Asymptomatic falciparum malaria and intestinal
helminths co-infection among school children in
Osogbo, Nigeria. J Res Med Sci 16: 680-686.
34. O’NEAL SE, GUIMARAES LH, MACHADO PR,
ALCANTARA L, MORGAN DJ, PASSOS S. GLESBY
MJ, CARVALHO EM. 2007. Influence of Helminth
Infections on the Clinical Course of and Immune
Response to Leishmania braziliensis Cutaneous
Leishmaniasis. J Infect Dis 195: 142-148.
35. OSADA Y, KANAZAWA T. 2010. Parasitic Helminths:
New Weapons against Immunological Disorders. J
Biomed Biotechnol, ID 743758, doi:10.1155/2010
/743758.
36. PAYNE RJH, TURNER L, MORGAN ER. 2009.
Inappropriate measures of population health for
parasitic disease? Trends Parasitol 25: 393-395.
37. POULIN R. 2007. Evolutionary ecology of parasites.
2nd ed. Princeton University Press.
38. PULLAN R, BROOKER S. 2008. The health impact
of polyparasitism in humans: are we under-estimating
the burden of parasitic diseases? Parasitology 135: 783-
794.
39. RASO G, LUGINBüHL A, ADJOUA CA, TIAN-
BI NT, SILUÉ KD, MATTHYS B, VOUNATSOU P,
WANG Y, DUMAS M-E, HOLMES E, SINGER BH,
TANNER M, N’GORAN EKN, UTZINGER J. 2004.
Multiple parasite infections and their relationship to
self-reported morbidity in a community of rural Coˆte
d’Ivoire. Int J Epidemiol 33: 1092-1102.
40. RODRIGUES CM, VALADARES HMS, FRAN-
CISCO AF, ARANTES JM, CAMPOS CF, TEIxEI-
RA-CARVALHO A, MARTINS-FILHO OA, SILVA
ARAUJO MS, ESTEVES ARANTES RM, CHIARI
E, FRANCO GR, MACHADO CR, JUNHO PENA
SD, CAETANO FARIA AM, MACEDO AM. 2010.
Coinfection with Different Trypanosoma cruzi Strains
Interferes with the Host Immune Response to Infection.
PLoS Negl Trop Dis 4, e846. doi:10.1371/journal.
pntd.0000846.
41. RODRÍGUEZ M, TERRAZAS LI, MARQUEZ R,
BOJALIL R. 1999. Susceptibility to Trypanosoma
cruzi is modified by a previous non-related infection.
Parasite Immunol 21: 177-185.
42. RODRÍGUEZ-SOSA M, RIVERA-MONTOYA I,
ESPINOZA A, ROMERO-GRIJALVA M, LÓPEZ-
Rev. Ibero-Latinoam. Parasitol. (2012); 71 (1): 5-13